FTC Continues Warnings to CBD Companies on Treatment Claims

Continuing to address treatment claims made by CBD companies, the FTC has announced it sent warning letters to three companies. Regulators have not revealed the identities of the CBD companies that received the warnings, though the agency has revealed the substance of the warning letters which include an explanation that it is illegal to advertise a product that can prevent or cure a disease without reliable scientific evidence to back up the claims. The agency reported that the claims made by the companies included such terms as “works like magic” and that the products relieved pain better than prescription opioid painkillers. One of the companies had made claims that its product was clinically proven to treat diseases such as Alzheimers and schizophrenia. The FTC has asked the companies to notify the agency of the actions they have taken to remedy these concerns.